Feb 25 (Reuters) - U.S. stocks struggled on Tuesday, with the S&P 500 and the Nasdaq touching one-month lows as a dour ...

Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded the range ...

Global Sports Technology Market is valued approximately at USD 13.33 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 19.73% over the forecast pe ...

Regeneron Pharmaceuticals said on Monday its experimental gene therapy showed improved hearing in 10 of 11 children between ...

The site is expected to accelerate Amgen’s digital capabilities through artificial intelligence and data science to further ...

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and ...

A shortage of Danish drugmaker Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, has been resolved, ...

The resolution comes two months after the health regulator said there was no longer a shortage of Eli Lilly's weight-loss and ...

As India awaits the launch of obesity drug, Mounjaro, the debate on weight loss drugs and body image continues ...

Some doctors say drugs that improve muscle mass could benefit older or infirm people at greater risk of falls and fractures.